Isomerase Revenue and Competitors
Estimated Revenue & Valuation
- Isomerase's estimated annual revenue is currently $8M per year.
- Isomerase's estimated revenue per employee is $201,000
Employee Data
- Isomerase has 40 Employees.
- Isomerase grew their employee count by -2% last year.
Isomerase Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Isomerase?
Isomerase Therapeutics is a biotechnology drug discovery and development service company exploiting the power of microbial natural products. We are uniquely placed to assist partners with their search for new highly targeted medicines, improved microbial products and the development of more cost-effective processes. We combine leading-edge synthetic biology, advanced strain bioengineering and biosynthetic medicinal chemistry approaches to discover new leads and rapidly optimise these into highly valuable drug candidates or high value products. We offer this bespoke biosynthetic engineering/semi-synthetic chemistry platform and drug discovery and development expertise on a FTE basis to partners looking for more than just a CRO. Isomerase Therapeutics can help you take your chosen natural product from an interesting hit to a high value candidate drug.
keywords:N/A
N/A
Total Funding
40
Number of Employees
$8M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Isomerase News
Fatty acid oxidation enzyme ?3, ?2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate...
Human triosephosphate isomerase (HsTIM) is a central glycolytic enzyme and is overexpressed in cancer cells with accelerated glycolysis.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5M | 40 | -7% | N/A |
#2 | $3.1M | 40 | -20% | $22.5M |
#3 | $4.6M | 40 | 60% | N/A |
#4 | $6.2M | 40 | 67% | N/A |
#5 | $3.5M | 40 | 14% | N/A |